|
Pipeline to Partnerships (P2P)
| Category/Phase: Therapeutics/Intervention / Other FDA |
  represents column sort |
|
|
Title
|
Company Name
|
Platform /
Modality
|
Target
|
Investor/Partner
Relations
|
| Human Ribonucleases to Treat Disease |
Quintessence Biosciences, Inc. |
Biologic |
Targets RNA in cancer cells |
VC, Licensing, Manufacturing, Strategic Partner |
| Novel Neurorestorative Agents (anti-inflammatory, neuroprotective and remyelinating) |
Cognosci, Inc. |
Other (peptides and small molecules) |
proprietary and novel |
VC, Licensing, Strategic Partner, Other |
| Oral probiotic therapy for kidney disease via enteric dialysis |
Kibow Biotech, Inc. |
Biologic |
uremic toxins - urea, creatinine, uric acid, etc. |
Licensing, Strategic Partner |
| ThermoSuit System |
Life Recovery Systems |
Point of Care |
|
VC, Licensing, Strategic Partner |
|
